{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:05:54Z","timestamp":1782252354359,"version":"3.54.5"},"reference-count":44,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:p><jats:bold>Aims:\u2002<\/jats:bold> Survivin is expressed in neoplastic cells and appears to be associated with resistance to therapy and shorter survival in various types of tumours. The aim of the present study was to determine whether nuclear or cytoplasmic expression of survivin is related to disease recurrence and overall survival of patients with Stage I and II melanoma according to the American Joint Committee on Cancer (AJCC) staging system.<\/jats:p><jats:p><jats:bold>Methods and results:\u2002<\/jats:bold> Immunohistochemistry was performed on formalin\u2010fixed paraffin\u2010embedded sections of primary cutaneous melanoma from 50 patients. Survival rates were estimated using the Kaplan\u2013Meier method and compared using the log rank test. Association of clinical variables (gender, age, tumour location, thickness, Clark level and AJCC stage) with survivin expression was analysed by Fisher's exact test. Patients with nuclear immunoreactivity for survivin had an increased risk of disease recurrence during the first three postoperative years (<jats:italic>P\u2003&lt;<\/jats:italic>\u20030.05) and of death (<jats:italic>P\u2003&lt;<\/jats:italic>\u20030.05). Cytoplasmic immunoreactivity was not correlated with either survival or clinical variables.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Nuclear presence of survivin may be an independent biomarker for disease recurrence and overall survival in patients with Stage I and II melanoma.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2007.02695.x","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T06:12:44Z","timestamp":1180678364000},"page":"835-842","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma"],"prefix":"10.1111","volume":"50","author":[{"given":"F","family":"Piras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Murtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Minerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Floris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Maxia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Colombari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M T","family":"Perra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sirigu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"209","volume-title":"AJCC cancer staging manual","author":"Balch CM","year":"2002"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2005.tb00361.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm830"},{"key":"e_1_2_7_5_2","first-page":"43","article-title":"Developmentally regulated expression of the novel cancer anti\u2010apoptosis gene survivin in human and mouse differentiation","volume":"152","author":"Adida C","year":"1998","journal-title":"Am. J. Pathol."},{"key":"e_1_2_7_6_2","first-page":"5071","article-title":"Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer","volume":"58","author":"Kawasaki H","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410614"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/25141"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.240390697"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.151.7.1575"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300957200"},{"key":"e_1_2_7_12_2","first-page":"2805","article-title":"A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy","volume":"60","author":"Olie RA","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc968"},{"key":"e_1_2_7_14_2","first-page":"2462","article-title":"Regulation of microtubule stability and mitotic progression by survivin","volume":"62","author":"Giodini A","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-002-8518-3"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20634"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.115.3.575"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20768"},{"key":"e_1_2_7_19_2","first-page":"1327","article-title":"Survivin apoptosis: an interloper between cell death and cell proliferation in cancer","volume":"79","author":"Altieri DC","year":"1999","journal-title":"Lab. Invest."},{"key":"e_1_2_7_20_2","first-page":"2377","article-title":"Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications","volume":"22","author":"Dong Y","year":"2002","journal-title":"Anticancer Res."},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602632"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602904"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20951"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00776.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63110-0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-005-0572-x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21727"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.066"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21267"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2005.00389.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.24.1893"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.54.3.131"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0682-z"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e02-11-0769"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10327"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.6496"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203665"},{"key":"e_1_2_7_38_2","first-page":"6097","article-title":"Survivin\u2010deltaEx3 and survivin\u20102B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties","volume":"59","author":"Mahotka C","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401091"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.12.178"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-4-11"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508773200"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.03.037"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422222"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208097"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2007.02695.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2007.02695.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:46:50Z","timestamp":1697172410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2007.02695.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,31]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1365-2559.2007.02695.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02695.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,31]]},"assertion":[{"value":"2007-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}